Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune Disorders

por Dussiau, Charles, Dupuy, Henry, Bidet, Audrey, Sauvezie, Mathieu, De-Grande, Anne-Charlotte, Boureau, Lisa, Riviere, Etienne, Forcade, Edouard, Bonnet, Fabrice, Dumas, Pierre-Yves, Duffau, Pierre, Pigneux, Arnaud, Viallard, Jean-François, Dimicoli-Salazar, Sophie, Lazaro, Estibaliz
Publicado 2023

S102: LUSPATERCEPT VERSUS EPOETIN ALFA FOR TREATMENT (TX) OF ANEMIA IN ESA-NAIVE LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS (PTS) REQUIRING RBC TRANSFUSIONS: DATA FROM...

por Della Porta, Matteo Giovanni, Platzbecker, Uwe, Santini, Valeria, Zeidan, Amer M., Fenaux, Pierre, Komrokji, Rami S., Shortt, Jake, Valcárcel, David, Jonášová, Anna, Dimicoli-Salazar, Sophie, Tiong, Ing Soo, Lin, Chien-Chin, LI, Jiahui, Zhang, Jennie, Carolina Giuseppi, Ana, Kreitz, Sandra, Pozharskaya, Veronika, Keeperman, Karen L., Rose, Shelonitda, Shetty, Jeevan K., Hayati, Sheida, Vodala, Sadanand, Degulys, Andrius, Paolini, Stefania, Cluzeau, Thomas, Garcia-Manero, Guillermo
Publicado 2023

Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms – results of the EUROPE trial by EMSCO

por Kubasch, Anne Sophie, Giagounidis, Aristoteles, Metzgeroth, Georgia, Jonasova, Anna, Herbst, Regina, Diaz, Jose Miguel Torregrosa, De Renzis, Benoit, Götze, Katharina S., Huetter-Kroenke, Marie-Luise, Gourin, Marie-Pierre, Slama, Borhane, Dimicoli-Salazar, Sophie, Cony-Makhoul, Pascale, Laribi, Kamel, Park, Sophie, Jersemann, Katja, Schipp, Dorothea, Metzeler, Klaus H., Tiebel, Oliver, Sockel, Katja, Gloaguen, Silke, Mies, Anna, Chermat, Fatiha, Thiede, Christian, Sapena, Rosa, Schlenk, Richard F., Fenaux, Pierre, Platzbecker, Uwe, Adès, Lionel
Publicado 2022